Marinol

DRUG3 trials

Sponsors

Jazz Pharmaceuticals, Par Pharmaceutical, Inc., Yehudith Assouline-Dayan

Conditions

Chest PainEvaluation of Abuse Potential of SativexTo Determine Bioequivalence Under Fasting Conditions

Phase 1

Abuse Potential of Sativex

CompletedNCT01323569

Jazz PharmaceuticalsEvaluation of Abuse Potential of Sativex

Start: 2008-02-29End: 2008-06-30Updated: 2023-04-10

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

CompletedNCT01380457

Par Pharmaceutical, Inc.To Determine Bioequivalence Under Fasting Conditions

Start: 2006-01-31End: 2006-04-30Updated: 2011-06-27

Phase 4

The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain

CompletedNCT01598207

Yehudith Assouline-DayanChest Pain

Start: 2011-02-28End: 2014-05-31Updated: 2017-04-28

Related Papers

A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial.

2015-08-147 citations